The New York-based health care products distributor made acquisitions in Australia and Brazil.
Latest In Pharmaceutical & Health Care
The acquisition is expected to close in 2023's third quarter.
It could take until the end of 2023 to complete, after which 3M will retain a 19.9% stake.
For the first nine months, sales were $133.9 billion, up 7.5% year-over-year.
Profit for the quarter was $477 million compared to a loss of $80 million in 2019.
The company reported a loss for the quarter of $14.1 million.
Brian Tyler succeeds John Hammergren in the role.
The acquisition would expand the lab-equipment companys presence in the field of gene therapy.
Healthcare distributor appoints Edward A. Pesicka to top post, effective March 4.
Fiscal second-quarter increase led by growth in the companys pharmaceuticals segment.
Distributor reports solid sales growth in the U.S., double-digit increase in medical-surgical solutions business.
Company hires Brian Rice as executive vice president, chief information officer and customer support services.
Distributor will move its headquarters from San Francisco to Las Colinas, Texas, effective April 1.
Fiscal first-quarter sales reach $35.2 billion, driven by growth in both pharmaceutical and medical segments.
Victor Crawford named CEO of distributors pharmaceutical segment, effective November 12.